RECOVER · Recovery care
GHK-Cu
Learn about copper peptide biology.
GHK-Cu is a copper-binding peptide studied in tissue biology. The route and formulation are central to interpreting that research.
Prescription required. Provider evaluation determines eligibility.
GHK-Cu consists of a peptide associated with copper. A topical preparation and an injectable preparation are different products.
Experimental work explores cellular signaling and tissue-related processes. Findings from those settings do not establish healing, hair growth or skin regeneration from an injection.
Directions depend on the route and actual preparation. The ingredient name alone does not tell you how a product should be used.
Review should address the clinical concern, route-specific evidence, medicines and product-specific risks.
Copper-binding peptide.
Evidence before expectation.
GHK-Cu consists of a peptide associated with copper. A topical preparation and an injectable preparation are different products.
-
Copper-binding peptide
GHK-Cu is a peptide complex involving copper.
-
Route changes the question
Topical research cannot establish injectable outcomes.
-
Evidence before expectation
Discuss what is known about the actual preparation.
Care starts with
understanding you.
A treatment decision should take your health history, current medications and goals into account. Your evaluation is the place to discuss questions, potential risks and whether another approach may be more appropriate.
-
Your health in context
Share your medical history, current medications and treatment goals.
-
A considered decision
Discuss the evidence, potential risks and available alternatives.
-
Clear next steps
If treatment is prescribed, follow the instructions for your exact medication and ask how follow-up will work.
Explore your options
with context.
Different treatments have different uses, risks and levels of evidence. Explore this care category, then discuss the options that may fit your clinical needs.
Explore recovery care-
BPC-157 Injection
Route and ingredient identity must be clear.
BPC-157 is a synthetic peptide. The proposed injectable formulation requires its own assessment of identity, evidence and quality.
Learn more -
BPC-157 Capsules
Route and ingredient identity must be clear.
These capsules contain BPC-157 in an oral preparation. They are distinct from an injectable formulation.
Learn more -
BPC-157/TB500
BPC-157 and TB-500.
This preparation combines BPC-157 and TB-500. The exact TB-500 identity and route must be confirmed.
Learn more
A plan begins with
an evaluation.
Completing an assessment does not guarantee a prescription.
-
Share your history
Provide information about your health, medications and goals.
-
Review the options
A licensed provider evaluates whether treatment is clinically appropriate. Further information, testing or another type of care may be needed.
-
Understand your prescription
If prescribed, review the medication, administration directions, risks and follow-up plan before starting.
-
Revisit the plan
Discuss your response and any concerns with your prescriber. Do not change a dose or combine treatments on your own.
Know the important
information.
Every medication has potential risks. Review the complete safety information for the exact product and tell your provider about your medical conditions, allergies, pregnancy or pregnancy plans, and all medicines and supplements you take.
Compounded medications are not FDA-approved. FDA does not evaluate these preparations for safety, effectiveness or quality before marketing.
Human safety data may be incomplete. Ingredient identity, purity, formulation and administration route matter; an ingredient’s research history does not establish the safety of a blend.
Seek emergency care for trouble breathing or swelling of the face, lips or throat. Contact a clinician promptly for severe or concerning symptoms. Do not rely on routine online messaging for an emergency.
Frequently asked questions
No. Administration and safety considerations differ.
Those outcomes are not established for the proposed preparation.
No. Giving a substance as treatment creates separate safety questions.
A licensed provider considers your health history, current medications, clinical needs and the evidence for the specific treatment. Further testing or a different type of care may be recommended.
No. A prescription is provided only when the evaluating provider determines that treatment is medically appropriate and available.
Follow your prescriber and pharmacy's instructions for the exact product. Ask before changing a dose, switching formulations or combining treatments.
Your next step starts with your
health.
Share your history and goals so a licensed provider can evaluate which care options may be appropriate for you.
Prescription required. Treatment is not appropriate for everyone. Assessment does not guarantee a prescription.